BURETTE SET MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The global burette set market is estimated to be valued at USD 620 Mn in 2026 and is expected to reach USD 1,020 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033. Also called measured volume infusion sets, burette sets are medical devices specifically engineered to provide controlled volumes of intravenous fluids, thus, being very important medical devices, especially when dealing with fragile patient population such as children and newborns.

Several factors have been pushing the growth of this market including the need to administer accurate volumes of fluids in clinical procedures, increased admission rates and patient safety concerns regarding infusion treatments. In addition, there has been an increase in the number of single-use devices because of the concern of infections resulting from reusable medical devices. Innovations include advancements in the safety of materials used for these medical devices (DEHP free), as well as improvement in their design to make them easier to use and accurate. Expansion of healthcare infrastructure in developing economies and low-cost products has also provided new opportunities for players in the burette set market.

Market Dynamics

The global burette set market has gained traction due to the increased need for accurate and well-controlled delivery of fluids intravenously. In cases involving patients in neonatal or pediatric wards, the precision of the dosage is paramount. The increased cases of hospitalization, number of surgeries performed, and rising number of people suffering from chronic ailments have also contributed to the uptake of burette sets. The increased concerns for patient safety and the need to develop consistent procedures of infusion in the hospitals have also supported the continuous uptake of burette sets.

Nevertheless, the growth of the market is restrained by several factors such as high costs of production for some products in certain regions and the presence of other types of infusion therapy equipment that can limit market differentiation. However, there are still plenty of opportunities in the market, with increasing trends towards using single-use products and DEHP-free PVC being two of the main ones. Another key opportunity is linked to expansion of healthcare facilities and rising interest in infant care.

Key Features of the Study

• This report provides in-depth analysis of the global burette set market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global burette set market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include B. Braun, Baxter International, Inc., PL Medical, Wellmed International Industries Pvt. Ltd., Merck, Thermo Fisher Scientific, Global Medikit Ltd., Angiplast Pvt. Ltd., APEX Medical Devices, and BQ Plus Medical Co. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global burette set market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global burette set market

Market Segmentation

• Capacity Insights (Revenue, USD Mn, 2021 - 2033)
  • ≤100 mL
  • 101–150 mL
  • >150 mL
  • Others
• Material Insights (Revenue, USD Mn, 2021 - 2033)
  • PVC
  • DEHP-free PVC
  • Others
• Patient Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Pediatric / Neonatal
  • Adult
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
  • Direct / Tender-based Procurement
  • Distributors and Wholesalers
  • Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Braun
  • Baxter International, Inc.
  • PL Medical
  • Wellmed International Industries Pvt. Ltd.
  • Merck
  • Thermo Fisher Scientific
  • Global Medikit Ltd.
  • Angiplast Pvt. Ltd.
  • APEX Medical Devices
  • BQ Plus Medical Co. Ltd.